FDA Withdraws UKONIQ (umbralisib) Approval

FDA Withdraws UKONIQ (umbralisib) Approval Over Safety Concerns

The FDA withdrew approval for a cancer medication known as umbralisib, used to treat marginal zone lymphoma and follicular lymphoma, over safety…

Read More »